Drugs / CARDIX-101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05117346 | Dec 2022 → Jun 2024 | — | Cardix Therapeutics LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CARDIX-101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05117346 ↗ |
| Route | Oral | “via oral administration” NCT05117346 ↗ |